Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus

Lignende værker

• Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
  af: Gardiner, Kyle M., et al.
  Udgivet: (2018)
• Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
  af: Jia, Yichen, et al.
  Udgivet: (2018)
• Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium with the Concomitant Use of Proton Pump Inhibitors in Patients who Received Kidney Transplant
  af: Aysu Selçuk, et al.
  Udgivet: (2022-10-01)
• Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
  af: Kim, Jae Hyun, et al.
  Udgivet: (2018)
• Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
  af: Jones, Rachel B., et al.
  Udgivet: (2014)